Twist Bioscience Surges 9.9 percent Is This an Indication of Further Gains?
| TWST Stock | USD 52.37 1.23 2.41% |
Slightly above 55% of Twist Bioscience's private investors are presently thinking to get in. The analysis of the overall investor sentiment regarding Twist Bioscience Corp suggests that some traders are interested. Twist Bioscience's investing sentiment can be driven by a variety of factors including economic data, Twist Bioscience's earnings reports, geopolitical events, and overall market trends.
Twist |
Twist Bioscience was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Read at zacks.com
 |
Twist Bioscience Fundamental Analysis
We analyze Twist Bioscience's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Twist Bioscience using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Twist Bioscience based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Gross Profit
Gross Profit Comparative Analysis
Twist Bioscience is currently under evaluation in gross profit category among its peers. Gross Profit is the most basic measure of business operational efficiency. It is simply the difference between sales revenue and the cost associated with making a product or providing a service. It is calculated before deducting administrative expenses, taxes, and interest payments.
Twist Bioscience Corp Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Twist Bioscience stock to make a market-neutral strategy. Peer analysis of Twist Bioscience could also be used in its relative valuation, which is a method of valuing Twist Bioscience by comparing valuation metrics with similar companies.
Peers
Twist Bioscience Related Equities
| CDNA | Caredx | 1.39 | ||||
| NTRA | Natera | 0.37 | ||||
| CSTL | Castle Biosciences | 0.18 | ||||
| A | Agilent Technologies | 0.09 | ||||
| EXAS | EXACT Sciences | 0.04 | ||||
| MTD | Mettler Toledo | 0 | ||||
| DHR | Danaher | 0.15 | ||||
| ILMN | Illumina | 0.20 | ||||
| IQV | IQVIA Holdings | 0.21 | ||||
| WAT | Waters | 0.43 | ||||
| ICLR | ICON PLC | 1.31 | ||||
| TMO | Thermo Fisher | 1.48 | ||||
| PSNL | Personalis | 2.61 | ||||
| GH | Guardant Health | 5.93 |
Additional Tools for Twist Stock Analysis
When running Twist Bioscience's price analysis, check to measure Twist Bioscience's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Twist Bioscience is operating at the current time. Most of Twist Bioscience's value examination focuses on studying past and present price action to predict the probability of Twist Bioscience's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Twist Bioscience's price. Additionally, you may evaluate how the addition of Twist Bioscience to your portfolios can decrease your overall portfolio volatility.